Opportunities
Search

This result matches because the title matches the main search terms, the type, category, tags, or source metadata support the match, the applicant profile aligns with startups.

Applicant type: Company.

Deadline: Nov 15, 2027.

The purpose of this Notice of Funding Opportunity (NOFO) is to leverage NICHD clinical research Network infrastructure relevant to infants, children, women, pregnant and lactating women, and persons with disabilities to conduct innovative, multisite, investigator-initiated clinical trials and observational studies. This NOFO will utilize a bi-phasic (UG3/UH3), milestone-driven mechanism consisting of a start-up phase (UG3) and a full enrollment and clinical trial implementation phase (UH3). Applications submitted in response to this NOFO must address specific aims and milestones for both the UG3 and UH3 phases. A UG3 project (phase I) that meets its milestones will be administratively considered by NICHD and prioritized for transition to the UH3 award (phase II). This NOFO provides an opportunity to leverage NICHD clinical research Network infrastructure as a platform for investigator-initiated innovative hypotheses by any investigator in the extramural community. Applications must be submitted as investigator-initiated, multi-Project Director/Principal Investigator (PD/PI) grant applications in conjunction with the respective NICHD-supported Network Data Coordinating Center (DCC), or equivalent as determined by the NICHD.

This result matches because the type, category, tags, or source metadata support the match, the summary or source description contains related terms.

Applicant type: Unknown.

Deadline is unknown; verify on the official source.

U.S. Embassy Praia welcomes the submission of project applications for funding through the Ambassador’s Special Self-Help Program (SSH). If interested, please carefully review the instructions below. The SSH is a grass-roots grant assistance program that allows U.S. Ambassadors to support local requests for small community-based development projects. The purpose of the Special Self-Help Program is to support communities through modest grants that will positively impact local communities. The SSH philosophy is to help communities help themselves. Projects submitted for SSH must align with one or more U.S. Embassy priorities:  Economic diversification, including small business creation and income generation  Projects must aim to 1) generate sustainable income and employment opportunities in local communities, 2) advance economic diversification and encourage use of local natural resources or income generation, 3) promote a culture of entrepreneurship, and/or 4) improve economic or living conditions of a community. Women start-ups and women entrepreneurs Eligible projects assist women who are launching a business or who are overseeing the early stages of business development (between one to two years). Such projects must promote a culture of women-led entrepreneurship and innovation that can be replicated in the community. Projects must also promote profitable businesses that gene...

This result matches because the title matches the main search terms, the type, category, tags, or source metadata support the match, the applicant profile aligns with startups.

Applicant type: Company.

Deadline: Jun 15, 2026.

The purpose of this Funding Opportunity Announcement is to invite proposals for funding from established organizations interested in providing innovative hands-on, in-person manufacturing training and technical assistance to eligible small manufacturing business concerns, under the U.S. Small Business Administration's Empower to Grow Program (formerly known as 7(j) Management and Technical Assistance Program).

This result matches because the title matches the main search terms, the type, category, tags, or source metadata support the match.

Applicant type: Unknown.

Deadline is unknown; verify on the official source.

This result matches because the title matches the main search terms, the type, category, tags, or source metadata support the match, the summary or source description contains related terms.

Applicant type: Consortium.

Deadline: Sep 15, 2027.

Expected Outcome:Project results are expected to contribute to the following outcomes:Increasing the market footprint of European startups in strategic digital technologies and deep tech[1] innovation, including but not limited to Artificial Intelligence, Advanced Computing, Cybersecurity, Next Generation Internet, Blockchain, Internet of Things, Metaverse, Energy, Greentech, AgriTech, and Fintech;Better connection of startups and scaleups, including European Institute of Innovation and Technology (EIT) and European Innovation Council (EIC)-supported startups and Seal of Excellence holders, to relevant local and/or European ecosystems, communities, and potential new markets;A scaling up of capabilities in matching technology solutions developed by highly innovative European Union (EU)-funded digital and deep tech startups with investment and growth opportunities in collaboration with oth...

This result matches because the title matches the main search terms, the type, category, tags, or source metadata support the match, the summary or source description contains related terms.

Applicant type: Consortium.

Deadline: Sep 22, 2026.

Expected Outcome:Project results are expected to contribute to the following outcomes:Increased commercialisation of academic research results, by facilitating access for industry, startups and scaleups to the intellectual assets of academic research;Strengthened collaboration between industry and academia, reflected in an increased number of technology transfer deals and joint R&D projects resulting in market-ready innovations;Introduced more startup friendly intellectual asset transfer/licensing policies in universities/research and higher education institutions/RTOs;Increased number of spinoffs by enabling researchers to overcome the barriers to commercialising their intellectual assets;Reduced transaction costs related to Intellectual Property Rights (IPR) negotiations by establishing more standardised asset transfer policies across universities/research and higher education institut...

This result matches because the type, category, tags, or source metadata support the match, the summary or source description contains related terms.

Applicant type: Unknown.

Deadline: Jul 27, 2026.

NSF invests in scientific discoveries, technological breakthroughs, and transformative innovations that strengthen economic growth, enhance security, and improve the lives of Americans and people around the world. Our ability to support that mission requires a robust scientific and engineering (S&E) enterprise in the United States that allows scientists to innovate at the frontier. In addition to funding scientists, America needs next-generation scientific instrumentation that allows scientists to pursue new innovations. In many fields, it is critical that this new scientific instrumentation is developed in the United States. In support of this mission, NSF is initiating a pilot emphasis area for itsSBIR/STTR programs to invest in startups and small businesses that are specifically developing enabling technologies that include next-generation instrumentation, novel experimental platforms, and other scientific equipment to advance the frontiers of scientific discovery and strengthen the American scientific and engineering enterprise. This encompasses novel instrumentation necessary for the coming era of AI-driven discoveries. This pilot will prioritize investing in the necessary infrastructure to support entirely new fields of scientific discovery, making new technological breakthroughs and transformative applications possible. Through this approach, NSF will continue to lead in...

This result matches because the type, category, tags, or source metadata support the match, the applicant profile aligns with startups, the summary or source description contains related terms.

Applicant type: Company.

Deadline: Jan 7, 2027.

The objective of this funding opportunity is to support investigator-initiated, Phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders in adults and children. In addition to supporting clinical trial start-up and implementation activities, this FOA will provide support for final stage preclinical activities needed for the implementation of the proposed trial. All the activities proposed in the R61 phase must be directly related to the therapeutic/diagnostic in preparation for the clinical trial. The proposed trial can be single or multisite. This NOFO will utilize a bi-phasic, milestone-driven mechanism of award where the first phase can be used to finalize required pre-trial activities such as stability, shipping studies, and site training.

This result matches because the type, category, tags, or source metadata support the match, the summary or source description contains related terms.

Applicant type: Consortium.

Deadline: Sep 22, 2027.

Expected Outcome:Successful proposals under this topic should contribute to the objectives of the EU Carbon Removals and Carbon Farming Certification (CRCF) Regulation and the Clean Industrial Deal, allowing industrial operators to use a sustainable carbon source as feedstock. They should facilitate innovators to scale up promising solutions in scope of the Strategy for European Life Sciences and the Biotech Act, also supporting the implementation of the EU Startup and Scaleup Strategy as well as the EU strategy on research and technology infrastructure.Project results are expected to contribute to all of the following expected outcomes:innovative and improved purification and conversion of gaseous carbon is developed and scaled up to provide feedstock for industrial processes promoting circularity and climate neutrality;advanced industries – applying life sciences technologies and biote...

This result matches because the type, category, tags, or source metadata support the match, the summary or source description contains related terms.

Applicant type: Consortium.

Deadline: Sep 22, 2027.

Expected Outcome:Project results are expected to contribute driving the innovation of public authorities and industrial operators confronted with the Biocidal products regulation (EC) No 528/2012, within the 'safe and sustainable by design' framework. The outcomes should support the goals of the Commission communication on: Building the future with nature: Boosting Biotechnology and Biomanufacturing in the EU, of the EU Startup and Scaleup Strategy, of the Strategy for European Life Sciences and of the new EU bioeconomy strategy.Project results are expected to contribute to all of the following expected outcomes:innovation in bio-based and natural substances brings safer alternatives to hazardous substances contained in biocidal products, with decreased risk on human health and biodiversity, including pollinators;safe, sustainable and effective solutions are developed and tested for the...

This result matches because the type, category, tags, or source metadata support the match, the summary or source description contains related terms.

Applicant type: Consortium.

Deadline: Sep 21, 2027.

Expected Outcome:Proposals under this topic should aim to deliver results that are directed and tailored towards, and contribute to all of the following expected outcomes:Patients with rare or very rare cancers or cancer subtypes have access to tailored, promising biomarker-guided medicines or multi-modal treatment interventions via participation in subsequent clinical trials or national or regional compassionate use programmes by health authorities;Researchers, physicians, innovators[1], startup, spin-off and spin-out companies, SMEs, charities or foundations and other professionals from different disciplines and sectors have access to innovative technology, medical devices or promising biomarker-guided medicines for further validation or commercialisation;National healthcare providers, policymakers and authorities in European regions, EU Member States and Associated Countries have earl...

This result matches because the type, category, tags, or source metadata support the match, the summary or source description contains related terms.

Applicant type: Consortium.

Deadline: Nov 4, 2027.

Expected Outcome:Project results are expected to contribute to some or all of the following expected outcomes:Development of a mature technological solution addressing EU security policy priorities in the areas addressed by the Cluster 3 work programme and in particular the destination of fighting crime and terrorism, disaster resilient societies, border management and resilient infrastructure;Facilitate increased and sustained collaboration between small and medium-sized enterprises (SMEs), public research partners, and academia, leading to improved knowledge transfer within the European innovative SME ecosystem;Mitigate difficulties in access to finance and new international markets, thereby enhancing the growth and expansion of European innovative SMEs. Scope:Europe’s 25 million small and medium enterprises (SMEs) are the backbone of the EU economy. SMEs can bring innovation to societ...

Expected Outcome:Project results are expected to contribute to all of the following expected outcomes:European industry’s competitiveness, decarbonisation, and strategic autonomy are enhanced through the development and deployment of safe, sustainable, circula...

Fit depends on applicant details and official eligibility rules.

Check deadline on the official source.

Expected Outcome:Project results are expected to contribute to all of the following expected outcomes:European industry’s competitiveness, decarbonisation, and strategic autonomy are enhanced through the development and deployment of safe, sustainable, circular and bio-based value chains;improved climate change adaptation and mitigation and overall environmental sustainability, as well as higher resource efficiency, through application of biotechnologies and industrial symbiosis, and recovery of biological materials, water and energy. Scope:The projects under this topic are relevant to the EU policies related to the Commission communication on: Building the future with nature: Boosting Biotechnology and Biomanufacturing in the EU, the Life Sciences Strategy, the EU Biotech Act, Clean Industrial Deal and the SME Strategy. It also contributes to the Start-ups and Scale-ups strategy. Synerg...